Scientific excellence with commercial acumen
The global bioeconomy is growing rapidly, as businesses realise the potential of biodesign and biomanufacturing. From novel materials to new medicines, data storage and living sensors, synthetic biology offers exciting new opportunities to sense, organise and process matter efficiently and cleanly – if you have the capability to turn theory into practice.
Using state-of-the-art facilities and techniques, our synthetic biology team fuses expertise in biology, chemistry and engineering to convert research-driven discovery into breakthrough products and services.
Background in biodesign
Our synthetic biology capability has grown organically from our long history in healthcare and life-sciences.
Recognising a new era of rational biodesign for products and processes is emerging, we created our synthetic biology division in 2015.
Antha is a programming language for biology that describes and executes complex protocols, driving massive productivity gains during biodesign.
Working in partnership with Synthace, we offer an end-to-end service to help clients launch Antha in their labs, delivering significant workflow efficiency benefits.
Biodesign is not fully predictive today and still requires extensive phenotypic characterisation and testing.
We designed an ultra-high throughput agar array-based system to measure ratiometric fluorescent signals from a library of transformed organisms and automatically identify the best-performing individual strain.
Interested in joining us?
Tech, tools & facilities
ケンブリッジ本社の微生物学ラボでは、微生物の遺伝子組み換えを実施することができます。当社の施設は、病原菌株を扱うためのバイオセーフティ・レベル 2であり、社内ライブラリにより、迅速なモジュール式 DNA の設計と組み立てが可能です。特にヘルスケアおよび産業用バイオテクノロジーの可能性に向け、バイオ・センサーとして機能する微生物に注力しています。
SGI BioXP 3200
This system is the world’s first benchtop automated genomic workstation that rapidly synthesizes high-quality, double-stranded DNA fragments and clones into any vector in an overnight run. Its numerous applications include protein production, antibody library generation and cell engineering.